Literature DB >> 6304145

Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss.

P D Delmas, D Stenner, H W Wahner, K G Mann, B L Riggs.   

Abstract

Because it is unclear whether age-related bone loss results from increased bone resorption, decreased bone formation or both, we measured the serum level of bone Gla-protein (BGP), a specific marker for bone turnover, in 174 women, ages 30 to 94 yr. Serum BGP increased linearly with aging (r = 0.44, P less than 0.001) from 4.4 +/- 0.4 (mean +/- SE) in the 4th decade to 8.9 +/- 0.9 ng/ml in the 10th decade. This increase correlated inversely (P less than 0.001) with concomitant decreases in bone mineral density at the lumbar spine, midradius, and distal radius. Using partial correlation coefficients, serum BGP still correlated positively with age (r = 0.31, P less than 0.001) after creatinine clearance was fixed but not with creatinine clearance (r = -0.04, NS) when age was fixed. Urinary hydroxyproline (r = 0.29, P less than 0.001), an index of bone resorption, and serum alkaline phosphatase (r = 0.31, P less than 0.001), an index of bone formation, also increased with age and these increases correlated with increases in serum BGP (r = 0.39, P less than 0.001 and r = 0.43, P less than 0.001, respectively). Serum immunoreactive parathyroid hormone concentrations (r = 0.39, P less than 0.001) and urinary cyclic AMP excretion (r = 0.38, P less than 0.001) increased, suggesting that PTH secretion increased with age; these increases correlated significantly with increases in serum BGP. A subgroup of 32 women who were found to have vertebral fractures, hip fractures, or both had significantly higher values for serum BGP than the remainder. These data suggest that overall bone turnover increases in women with aging and, especially considering the concomitant decrease in skeletal mass, do not support the view that age-related bone loss results primarily from decreased bone formation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304145      PMCID: PMC436993          DOI: 10.1172/jci110882

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Characterization of a gamma-carboxyglutamic acid-containing protein from bone.

Authors:  P A Price; A A Otsuka; J W Poser; J Kristaponis; N Raman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

2.  Modifications of a specific assay for hydroxyproline in urine.

Authors:  K I Kivirikko; O Laitinen; D J Prockop
Journal:  Anal Biochem       Date:  1967-05       Impact factor: 3.365

3.  Diagnosis of osteoporosis: usefulness of photon absorptiometry at the radius.

Authors:  H W Wahner; B L Riggs; J W Beabout
Journal:  J Nucl Med       Date:  1977-05       Impact factor: 10.057

4.  Physiological senile involution and pathological rarefaction of bone. Quantitative and comparative histological data.

Authors:  P Meunier; P Courpron; C Edouard; J Bernard; J Bringuier; G Vignon
Journal:  Clin Endocrinol Metab       Date:  1973-07

5.  A quantitative histological study on bone formation in human cancellous bone.

Authors:  W A Merz; R K Schenk
Journal:  Acta Anat (Basel)       Date:  1970

6.  Menopausal changes in bone remodeling.

Authors:  R P Heaney; R R Recker; P D Saville
Journal:  J Lab Clin Med       Date:  1978-12

7.  Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age.

Authors:  P Lips; P Courpron; P J Meunier
Journal:  Calcif Tissue Res       Date:  1978-11-10

8.  Bone resorption rates in rib in physiological, senile, and postmenopausal osteoporoses.

Authors:  K Wu; S Jett; H M Frost
Journal:  J Lab Clin Med       Date:  1967-05

9.  Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue.

Authors:  P V Hauschka; J B Lian; P M Gallop
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

10.  Radioimmunoassay of human parathyroid hormone in serum.

Authors:  C D Arnaud; H S Tsao; T Littledike
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

View more
  60 in total

1.  Sex does not influence serum osteocalcin levels in standardbred horses of different ages.

Authors:  O M Lepage; M Marcoux; A Tremblay; G Dumas
Journal:  Can J Vet Res       Date:  1992-10       Impact factor: 1.310

2.  The effect of bilateral oophorectomy on bone mineral density.

Authors:  Alper Hayirlioglu; Hüsnü Gökaslan; Nurten Andaç
Journal:  Rheumatol Int       Date:  2006-05-20       Impact factor: 2.631

3.  Serum bone Gla protein in streak gonad syndrome.

Authors:  J Zséli; P Bösze; P Lakatos; P Vargha; G Tarján; E Kollin; C Horváth; J László; I Holló
Journal:  Calcif Tissue Int       Date:  1991-06       Impact factor: 4.333

4.  Serum osteocalcin (bone Gla-protein) following corticosteroid therapy in postmenopausal women with rheumatoid arthritis. Comparison of the effect of prednisone and deflazacort.

Authors:  C Montecucco; F Baldi; A Fortina; G Tomassini; R Caporali; E L Cherie-Ligniere; P Fratino
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

5.  Calciotropic hormones in elderly people with and without hip fracture.

Authors:  C L Benhamou; D Tourliere; J B Gauvain; G Picaper; M Audran; P Jallet
Journal:  Osteoporos Int       Date:  1995-03       Impact factor: 4.507

6.  Sexual differences in bone markers and bone mineral density of normal Chinese.

Authors:  K S Tsai; W H Pan; S H Hsu; W C Cheng; C K Chen; P U Chieng; R S Yang; S T Twu
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

7.  Impaired vitamin D metabolism with aging in women. Possible role in pathogenesis of senile osteoporosis.

Authors:  K S Tsai; H Heath; R Kumar; B L Riggs
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

Review 8.  Pathogenetic aspects of involutional osteoporosis.

Authors:  G F Mazzuoli; E D'Erasmo; S Minisola; S Tabolli; F Bigi; G Bianchi
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

9.  Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption.

Authors:  R Eastell; S P Robins; T Colwell; A M Assiri; B L Riggs; R G Russell
Journal:  Osteoporos Int       Date:  1993-09       Impact factor: 4.507

10.  Vitamin K-induced changes in markers for osteoblast activity and urinary calcium loss.

Authors:  M H Knapen; K S Jie; K Hamulyák; C Vermeer
Journal:  Calcif Tissue Int       Date:  1993-08       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.